CMS Acknowledges Stakeholder Concerns Over Decision Not to Cover Germline NGS in Early Cancer Patients

The Centers for Medicare & Medicaid Services issued a notice this week acknowledging the confusion over its coverage policy for germline next-generation sequencing for cancer patients.

“CMS is sensitive to the concerns of its stakeholders regarding the interpretation of this policy and will work with the [Medicare administrative contractors] to adjust their respective claims processing systems accordingly,” the agency said in a transmittal to labs this week.

Source: https://www.360dx.com/reimbursement/cms-acknowledges-stakeholder-concerns-over-decision-not-cover-germline-ngs-early